enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
8.68
-0.03 (-0.34%)
At close: Mar 6, 2026, 4:00 PM EST
8.60
-0.08 (-0.92%)
After-hours: Mar 6, 2026, 7:06 PM EST
enGene Holdings Employees
As of October 31, 2025, enGene Holdings had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year.
Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,430,512
Market Cap
581.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 82 | 25 | 43.86% |
| Oct 31, 2024 | 57 | 24 | 72.73% |
| Oct 31, 2023 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| Rigel Pharmaceuticals | 164 |
| Vor Biopharma | 154 |
| Alpha Tau Medical | 125 |
| Ocugen | 95 |
| Verastem | 78 |
| Larimar Therapeutics | 65 |
| Design Therapeutics | 55 |
ENGN News
- 15 days ago - enGene to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Business Wire
- 5 weeks ago - enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 - Seeking Alpha
- 6 weeks ago - enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - Business Wire
- 2 months ago - enGene Reports Full Year 2025 Financial Results and Provides Business Update - Business Wire
- 3 months ago - enGene's Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness - Business Wire
- 3 months ago - enGene to Present at the Piper Sandler 37th Annual Healthcare Conference - Business Wire
- 4 months ago - enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants - Business Wire